Trehalose pathway as an antifungal target

Area of Science:

• Mycology
• Biochemistry
• Drug Discovery

Background:

• Increasing immunocompromised populations are susceptible to invasive fungal infections.
• Current antifungal agents face challenges from widespread use, leading to drug resistance.
• There is an urgent need for novel antifungal agents and a robust drug discovery pipeline.

Purpose of the Study:

• To characterize the trehalose metabolic pathway in fungi.
• To evaluate the trehalose pathway as a potential target for new antifungal agents.
• To explore the feasibility of developing specific inhibitors for fungal trehalose enzymes.

Main Methods:

• Review of existing literature on fungal trehalose metabolism.
• Analysis of the trehalose pathway's characteristics for antifungal development.
• Assessment of the pathway's presence and absence in mammalian systems.

Main Results:

• The trehalose pathway exhibits fungicidal characteristics.
• This pathway is broad-spectrum, effective across Ascomycete and Basidiomycete species.
• The pathway is absent in mammals, suggesting theoretical low toxicity for specific inhibitors.

Conclusions:

• The trehalose pathway presents a viable target for antifungal drug discovery.
• Targeting trehalose synthesis could lead to a new class of antifungal drugs.
• Developing specific inhibitors for fungal trehalose enzymes may offer a safe and effective treatment strategy.